Many studies have evidenced the protumorigenic activity of YES1 in a wide variety of solid tumors, such as breast cancer [146], prostate cancer [147], gastric cancer [148], liver cancer [149], NSCLC [150] and SCLC [151], among others. The gene discussed is YES1; the disease is non-small cell lung carcinoma.